Results do not support routine closure of the left atrial appendage in all patients undergoing open-heart surgery, but those at high stroke risk may benefit. This was the main conclusion of the LAACS-2 trial presented in a Hot Line session today at ESC Congress 2026.
Tailored Approach to Left Atrial Appendage Closure in Open-Heart Surgery: Benefits for High-Risk Patients
The LAACS-2 trial presented at ESC Congress 2026 concluded that routine closure of the left atrial appendage during open-heart surgery is not beneficial for all patients, but may be advantageous for those at high stroke risk. This finding is relevant for healthcare practices in Iran, particularly in managing patients with cardiovascular issues. The trial highlights the need for tailored medical approaches rather than one-size-fits-all solutions.
👥 Key Players
📰 What Happened
The LAACS-2 trial presented findings that routine closure of the left atrial appendage during open-heart surgery is not necessary for all patients, but could benefit those at high risk of stroke. This was shared during a session at the ESC Congress 2026.
- Routine closure is not beneficial for all open-heart surgery patients.
- High-risk patients may see advantages from the procedure.
💡 Why It Matters
📚 Background
The left atrial appendage is a small pouch in the heart that can lead to blood clots, especially in patients with atrial fibrillation. Understanding when to close it during surgery is crucial for patient outcomes.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%